These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22277410)

  • 21. Epidemiology of progressive muscular dystrophy in Okinawa, Japan. Classification with molecular biological techniques.
    Nakagawa M; Nakahara K; Yoshidome H; Suehara M; Higuchi I; Fujiyama J; Nakamura A; Kubota R; Takenaga S; Arahata K
    Neuroepidemiology; 1991; 10(4):185-91. PubMed ID: 1745328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular-genetic study of Duchenne and Becker muscular dystrophies: deletion analyses of 45 Japanese patients and segregation analyses in their families with RFLPs based on the data from normal Japanese females.
    Sugino S; Fujishita S; Kamimura N; Matsumoto T; Wapenaar MC; Deng HX; Shibuya N; Miike T; Niikawa N
    Am J Med Genet; 1989 Dec; 34(4):555-61. PubMed ID: 2576185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The TREAT-NMD care and trial site registry: an online registry to facilitate clinical research for neuromuscular diseases.
    Rodger S; Lochmüller H; Tassoni A; Gramsch K; König K; Bushby K; Straub V; Korinthenberg R; Kirschner J
    Orphanet J Rare Dis; 2013 Oct; 8():171. PubMed ID: 24148153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perturbation of muscle metabolism in patients with muscular dystrophy in early or acute phase of disease: In vitro, high resolution NMR spectroscopy based analysis.
    Srivastava NK; Yadav R; Mukherjee S; Sinha N
    Clin Chim Acta; 2018 Mar; 478():171-181. PubMed ID: 29278724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Duchenne/Becker muscular dystrophy: from molecular diagnosis to gene therapy.
    Matsuo M
    Brain Dev; 1996; 18(3):167-72. PubMed ID: 8836495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene deletions in Japanese patients with Duchenne and Becker muscular dystrophies: deletion study and carrier detection.
    Asano J; Tomatsu S; Sukegawa K; Ikedo Y; Minami R; Iida M; Nishimura M; Nakagawa M; Ohshiro M; Orii T
    Clin Genet; 1991 Jun; 39(6):419-24. PubMed ID: 1863988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Overview of Recent Advances and Clinical Applications of Exon Skipping and Splice Modulation for Muscular Dystrophy and Various Genetic Diseases.
    Rodrigues M; Yokota T
    Methods Mol Biol; 2018; 1828():31-55. PubMed ID: 30171533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of glucocorticoid therapy on the inflammatory and dendritic cells in muscular dystrophies.
    Hussein MR; Hamed SA; Mostafa MG; Abu-Dief EE; Kamel NF; Kandil MR
    Int J Exp Pathol; 2006 Dec; 87(6):451-61. PubMed ID: 17222213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DMDtoolkit: a tool for visualizing the mutated dystrophin protein and predicting the clinical severity in DMD.
    Zhou J; Xin J; Niu Y; Wu S
    BMC Bioinformatics; 2017 Feb; 18(1):87. PubMed ID: 28152980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The DM-scope registry: a rare disease innovative framework bridging the gap between research and medical care.
    De Antonio M; Dogan C; Daidj F; Eymard B; Puymirat J; Mathieu J; Gagnon C; Katsahian S; ; Hamroun D; Bassez G
    Orphanet J Rare Dis; 2019 Jun; 14(1):122. PubMed ID: 31159885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy: A Randomized Clinical Trial.
    Silva MC; Magalhães TA; Meira ZM; Rassi CH; Andrade AC; Gutierrez PS; Azevedo CF; Gurgel-Giannetti J; Vainzof M; Zatz M; Kalil-Filho R; Rochitte CE
    JAMA Cardiol; 2017 Feb; 2(2):190-199. PubMed ID: 27926769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identifying Non-Duchenne Muscular Dystrophy-Positive and False Negative Results in Prior Duchenne Muscular Dystrophy Newborn Screening Programs: A Review.
    Gatheridge MA; Kwon JM; Mendell JM; Scheuerbrandt G; Moat SJ; Eyskens F; Rockman-Greenberg C; Drousiotou A; Griggs RC
    JAMA Neurol; 2016 Jan; 73(1):111-6. PubMed ID: 26594870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dystrophin as a diagnostic marker in Duchenne and Becker muscular dystrophy. Correlation of immunofluorescence and western blot.
    Voit T; Stuettgen P; Cremer M; Goebel HH
    Neuropediatrics; 1991 Aug; 22(3):152-62. PubMed ID: 1944822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of swallowing dysfunction in Becker muscular dystrophy and Duchenne muscular dystrophy.
    Yamada Y; Kawakami M; Wada A; Otsuka T; Muraoka K; Liu M
    Disabil Rehabil; 2018 Jun; 40(12):1421-1425. PubMed ID: 28288529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of gene deletion in patients of Duchenne muscular dystrophy/Becker muscular dystrophy using polymerase chain reaction.
    Sinha S; Pradhan S; Mittal RD; Mittal B
    Indian J Med Res; 1992 Oct; 96():297-301. PubMed ID: 1459673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and Genetic Profile of Duchene and Becker Muscular Dystrophy in Puerto Rico.
    Ramos E; Conde JG; Berrios RA; Pardo S; Gómez O; Mas Rodríguez MF
    J Neuromuscul Dis; 2016 May; 3(2):261-266. PubMed ID: 27854217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global muscular dystrophy research: A 25-year bibliometric perspective.
    Ram S
    Neurol India; 2017; 65(5):993-1000. PubMed ID: 28879884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Valley sign in Becker muscular dystrophy and outliers of Duchenne and Becker muscular dystrophy.
    Pradhan S
    Neurol India; 2004 Jun; 52(2):203-5. PubMed ID: 15269471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA analysis of Duchenne and Becker muscular dystrophy using pERT87 genomic probes and dystrophin cDNA probes--establishing the optimum strategy for carrier diagnosis in the Japanese population.
    Ubagai T; Katayama S
    Jinrui Idengaku Zasshi; 1991 Sep; 36(3):211-27. PubMed ID: 1684391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.